Steffen Pietzke Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Steffen Pietzke.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Steffen Pietzke. Steffen Pietzke is Controller and CAO in PDL BIOPHARMA, INC. ($PDLI) and VP, Finance and CAO in PDL BIOPHARMA, INC. ($PDLI) and VP Fin & Chief Acct Officer in Tricida, Inc. ($TCDA) and VP Fin & Chief Acct Officer in ALX ONCOLOGY HOLDINGS INC ($ALXO).
Latest Insider Trading Transactions of Steffen Pietzke
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALXO, PDLI, TCDA
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Pietzke Steffen | VP Fin & Chief Acct ... | Buy | P | 19.00 | 3,000 | 57,000 | 3,000 | 0 to 3 K |
| Jul 17 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Pietzke Steffen | VP Fin & Chief Acct ... | Option Exercise | A | 19.00 | 41,789 | 793,991 | 41,789 | |
| Feb 26 2020 | TCDA | Tricida, Inc. | Pietzke Steffen | VP Fin & Chief Acct ... | Option Exercise | A | 35.12 | 60,000 | 2,107,200 | 60,000 | |
| Aug 23 2019 | TCDA | Tricida, Inc. | Pietzke Steffen | VP Fin & Chief Acct ... | Option Exercise | A | 34.27 | 10,000 | 342,700 | 10,000 | |
| Jul 02 2018 | TCDA | Tricida, Inc. | Pietzke Steffen | VP Fin & Chief Acct ... | Buy | P | 19.00 | 10,527 | 200,013 | 10,527 | 0 to 10.5 K |
| Dec 19 2017 | PDLI | PDL BIOPHARMA, INC ... | Pietzke Steffen | VP, Finance and CAO | Sell | D | 0.00 | 5,513 | 0 | 139,587 | 145.1 K to 139.6 K (-3.80 %) |
| Mar 07 2017 | PDLI | PDL BIOPHARMA, INC ... | Pietzke Steffen | Controller and CAO | Grant | A | 2.04 | 98,039 | 200,000 | 145,100 | 47.1 K to 145.1 K (+208.32 %) |
| Dec 15 2016 | PDLI | PDL BIOPHARMA, INC ... | Pietzke Steffen | Controller and CAO | Sell | D | 0.00 | 663 | 0 | 47,061 | 47.7 K to 47.1 K (-1.39 %) |
| Jan 28 2016 | PDLI | PDL BIOPHARMA, INC ... | Pietzke Steffen | Controller and CAO | Grant | A | 3.22 | 31,135 | 100,255 | 47,724 | 16.6 K to 47.7 K (+187.68 %) |
| Dec 07 2015 | PDLI | PDL BIOPHARMA, INC ... | Pietzke Steffen | Controller and CAO | Buy | P | 3.64 | 20,590 | 74,931 | 20,590 | 0 to 20.6 K |
| Oct 05 2015 | PDLI | PDL BIOPHARMA, INC ... | Pietzke Steffen | Controller and CAO | Grant | A | 4.95 | 1,841 | 9,113 | 16,589 | 14.7 K to 16.6 K (+12.48 %) |
| Jul 08 2015 | PDLI | PDL BIOPHARMA, INC ... | Pietzke Steffen | Controller and CAO | Grant | A | 6.18 | 14,748 | 91,143 | 14,748 | 0 to 14.7 K |
Page: 1